IMVT
Immunovant, Inc. · Healthcare
Chief Executive Officer Eric Venker sold $119K of Immunovant, Inc.
Sold$118,980
$38.48Price
3,092Shares
−1%Stake
What IMVT did after the filing
- The stock from Tue, Jul 7 open, $38.89
- +15.6%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 19 close.
Traded Thu, Jul 2. Filed Mon, Jul 6, 5:01 PM ET, after the close. Returns use the Jul 7 open and the Aug 19 close. Not investment advice.